Stoke Therapeutics Inc (NASDAQ: STOK)

Analyzing STOK’s current quarter earnings projections
Preston Campbell
Stoke Therapeutics Inc (STOK)’s stock is trading at $21.57 at the moment marking a fall of -14.88% from the last ...

Stoke Therapeutics Inc (STOK)’s stock is trading at $21.57 at the moment marking a fall of -14.88% from the last ...